|
1 Liang AL，Liu H. Progress in diagnosis and treatment of borderline ovarian tumors[J/CD]．Chin J Obstet Gynecol Pediatr (Electron Ed), 2009, 5(5)：542-545.[梁叆琳，刘辉．卵巢交界性肿瘤的诊治进展[J/CD].中华妇幼临床医学杂志：电子版，2009, 5(5)：542-545.]
|
|
2 Han XY, Chen Y, Hou MM，et al.A study on the expression and clinical significance of AIB1 protein in ovarian borderline epithelial tumor[J/CD]．Chin J Obstet Gynecol Pediatr (Electron Ed), 200 8，4(3)：186-190. [韩肖燕，陈悦，侯敏敏，等．卵巢上皮性交界瘤中AIB1蛋白的表达意义[J/CD].中华妇幼临床医学杂志：电子版，2008，4(3)：186-190.]
|
|
3 Qie MR. Reproductive prognosis after conservative treatments of ovarian cancer[J/CD]. Chin J Obstet Gynecol Pediatr (Electron Ed), 2006，2(2)：67-69. [郄明蓉．卵巢癌保留生育治疗[J/CD].中华妇幼临床医学杂志：电子版，2006，2(2)：67-69.]
|
|
4 Fauvet R, Boccara J, Dufournet C, et al. Laparoscopic management of borderline ovarian tumors：Results of a French multicenter study[J]. Ann Oncol, 2005, 16(3)：403-410.
|
|
5 Camatte S, Morice P, Atallah D, et al. Clinical outcome after laparoscopic pure management of borderline ovarian tumors：Results of a series of 34 patients[J]. Ann Oncol, 2004, 15(4)：605-609.
|
|
6 Donnez J, Munschke A, Berliere M, et al. Safety of conservative management and fertility outcome in women with borderline tumors of the ovary[J]. Fertil Steril, 2003, 79(5)：1216-1221.
|
|
7 Yu XJ, Guo XM, Jiang S. Prognosis and reproductive functions after conservative management in patients with borderline ovarian tumors[J]. China Oncol, 2001, 11(6)：543-546.[于兴江，郭秀敏，江森．保守性手术对交界性卵巢肿瘤预后及生育功能的影响[J].中国癌症杂志，2001, 11(6)：543-546.]
|
|
8 Boran N, Cil AP, Tulunay G, et al. Fertility and recurrence results of conservative surgery for borderline ovarian tumors[J]. Gynecol Oncol, 2005, 97(3)：845-851.
|
|
9 Camatte S, Deffieux X, Castaigne D, et al. Laparoscopic treatment of borderline ovarian tumor：Analysis of 54 patients and clinical outcomes[J]. Gynecol Obstet Fertil, 2005, 33(6)：395-402.
|
|
10 Swanton A, Bankhead CR, Kehoe S. Pregnancy rates after conservative treatment for borderline ovarian tumours：A systematic review[J]. Eur J Obstet Gynecol Reprod Biol, 2007, 135(1)：3-7.
|
|
11 Morice P, Camatte S, Wicart-Poque F, et al. Results of conservative management of epithelial malignant and borderline ovarian tumours[J]. Hum Reprod Update, 2003, 9(2)：185-192.
|
|
12 Fasouliotis SJ, Davis O, Schattman G, et al. Safety and efficacy of infertility treatment after conservative management of borderline ovarian tumors：A preliminary report[J]. Fertil Steril, 2004, 82(3)：568-572.
|
|
13 Cao ZY, ed. Chinese obstetrics and gynecology. 2 th ed[M]. Beijing: People's Medical Publishing House, 2004, 12-15.[曹泽毅，主编．中华妇产科学. 2版[M]．北京：人民卫生出版社，2004, 12-15.]
|
|
14 Querleu D, Gladieff L, Delannes M, et al. Preservation of fertility in gynaecologic cancers[J]. Bull Cancer, 2008, 95(5)：487-494.
|
|
15 Seli E, Tangir J. Fertility preservation options for female patients with malignancies[J]. Curr Opin Obstet Gynecol, 2005, 17(3)：299-308.
|
|
16 Schilder JM, Thompson AM, DePriest PD, et al. Outcome of reproductive age women with stage ⅠA or ⅠC invasive epithelial ovarian cancer treated with fertility-sparing therapy[J]. Gynecol Oncol, 2002, 87(1)：1-7.
|
|
17 Morice P, Leblanc E, Rey A, et al. Conservative treatment in epithelial ovarian cancer：Results of a multicentre study of the GCCLCC (Groupe des Chirurgiens de Centre de Lutte Contre le Cancer) and SFOG (Societe Francaise d'Oncologie Gynecologique)[J]. Hum Reprod, 2005, 20(5)：1379-1385.
|
|
18 Sagae S, Sasaki H, Nishioka Y, et al. Reproductive function after treatment of malignant germ cell ovarian tumors[J]. Mol Cell Endocrinol, 2003, 202(1-2)：117-121.
|
|
19 Tung KH, Goodman MT, Wu AH, et al. Reproductive factors and epithelial ovarian cancer risk by histologic type：A multiethnic case-control study[J]. Am J Epidemiol, 2003, 158(7)：629-638.
|
|
20 Tangir J, Zelterman D, Ma W, et al. Reproductive function after conservative surgery and chemotherapy for malignant germ cell tumors of the ovary[J]. Obstet Gynecol, 2003, 101(2)：251-257.
|
|
21 Han JY, Nava-Ocampo AA, Kim TJ, et al. Pregnancy outcome after prenatal exposure to bleomycin, etoposide and cisplatin for malignant ovarian germ cell tumors：Report of 2 cases[J]. Reprod Toxicol, 2005, 19(4)：557-561.
|
|
22 Mendez LE, Mueller A, Salom E, et al. Paclitaxel and carboplatin chemotherapy administered during pregnancy for advanced epithelial ovarian cancer[J]. Obstet Gynecol, 2003, 102(5 Pt 2)：1200-1202.
|
|
23 Rostgaard K, Wohlfahrt J, Andersen PK, et al. Does pregnancy induce the shedding of premalignant ovarian cells[J]? Epidemiology, 2003, 14(2)：168-173.
|
|
24 Steinkampf MP, Dharia SP, Hammond K, et al. Assisted reproduction in patients with early-stage ovarian malignancies[J]. Fertil Steril, 2003, 80(6)：1510-1512.
|
|
25 Gurgan T, Salman C, Demirol A. Pregnancy and assisted reproduction techniques in men and women after cancer treatment[J]. Placenta, 2008, 29(Suppl B)：152-159.
|
|
26 Pike MC, Pearce CL, Peters R, et al. Hormonal factors and the risk of invasive ovarian cancer：A population-based case-control study[J]. Fertil Steril, 2004, 82(1)：186-195.
|